| Hyperthermia Combined with Radiation and Androgen Therapy Provides ...
BSD Medical Corp. (AMEX:BSM) today announced that the International Journal of Hyperthermia has published the preliminary results of a phase II clinical study involving 144 patients with locally advanced prostate cancer. In this study BSD Medical's BSD-2000 hyperthermia system was used to deliver local hyperthermia combined with conformal radiation therapy and androgen suppression therapy in the treatment of prostate cancer. Hyperthermia combined with radiation and androgen therapy demonstrated results in survival similar to treatments using higher radiation doses, with no significant side effects associated with either hyperthermia or radiation therapy. The report is entitled "Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: Preliminary results of a prospective phase II study" (see Int.
IMRT spares bladder in prostate radiation
BOSTON, Oct. 11 Intensity modulated radiation therapy, or IMRT, spares the bladder more from direct radiation compared to 3-D conformal proton therapy, a U.S. study found.
The Massachusetts General Hospital Department of Radiation Oncology and Harvard Medical School, both in Boston, jointly conducted the study to determine the comparative benefits and drawbacks of IMRT versus 3D-CPT as treatments for patients with prostate cancer and to determine whether specific cases should be assigned to one treatment method over the other.
"This study was important because it reassures a patient with prostate cancer that the methods that are available at his local hospital may, in many cases, be as good as those that are currently only available in a limited number of centers," study author Dr.
Olmert says he has prostate cancer
Prostate cancer and treatment options are in public focus as Israeli PM Olmert reveals that he has prostate cancer, but will stay on the post. Israel's Prime Minister Ehud Olmert said on Monday he had prostate cancer, but that it was not life-threatening, and he would continue to perform his duties. "I have a tumor of the prostate in the very early stages... It is a minor tumor that can be surgically removed. This is not life-threatening and is treatable," he told a news conference. Olmert said the tumor was revealed during a routine medical examination, and it will not require radiation treatment or chemotherapy The consulting physicians told the news conference the tumor did not require urgent surgery, and that in such cases surgery to remove the tumor was usually performed no earlier than six weeks after the initial biopsy.
|
